Julian Leland

Experience

• 

  University of Central Florida

  Mar 2010 - Jun 2012

  Research Associate

  Project 1: Engineered nano-photonic materials aimed to extend the quantum yield and triplet lifetime of phosphorescent molecules using hybrid Au/Ag nano-spheres. Principal Investigator: Dr. F.E. HernandezReport: http://www.julianleland.com/wp-content/uploads/2013/08/Project1report.docxProject 2: Conducted Friedel-Crafts acylation experiments using natural products and fluorescent bio-makers in order to develop potential drugs to be used in PET scanning. Principal Investigator: Dr. D.H. MilesReport: http://www.julianleland.com/wp-content/uploads/2013/08/Project2report.docx Show less

• 

  East Coast Institute For Research

  May 2013 - Dec 2014

  Clinical Research Assistant

  Assist in internal clinical protocol audits and compliance. Screen patients' medical charts for enrollment in clinical trials. Collect and submit samples from clinical trial participants.  Interact with medical science liaisons on current and planned clinical research. Composed a training guideline for Diabetes education. ECIR’s “Discovery” newsletter contributor.

• 

  FDA

  Mar 2015 - Apr 2015

  Regulatory Affairs Intern

  CDER: Office of Medical Policy (Clinical Methodologies)• Identify, research and address opportunities and new proposals to improve clinical trial regulations.• Research and report on clinical trial decisions trends in regards to dose exploration, choice of endpoints, and safety/efficacy outcomes. • Focused on innovative clinical trial policies and prospective implementation & development strategies. • Observe medical policy management for the Center and FDA guidance proposals.• Search and evaluate literature on off-label treatment usage for orphan and emerging diseases.• Assisted in creating a searchable database for drugs/biologics and their FDA approved usage. Show less

• 

  Xcenda

  May 2015 - Jun 2015

  Managed Markets & Access Strategy Extern

  • New business development proposal: Rociletinib, market launch and access strategies• New business development primer: Gilead’s tenofovir alafenamide treatment & other HIV pipeline drugs• Analyze strategies for Gilead’s Latairis and tadalafil combinational drug for potential placement in pulmonary arterial hypertension guidelines/pathways using data from the AMBITION trial.• Investigate Clinical Commissioning Groups in the U.K. and evaluate its coverage in correlation to NICE guidelines• Review manuscripts for publication in JMCP and give editorial recommendations Show less

• 

  UF Health

  Aug 2015 - Feb 2016

  Clinical Pharmacy Intern

  Drug Safety and Information Department• Complete both retrospective and prospective analysis in the investigation of medication errors and quality initiatives. Report all suspected drug related adverse events to FDA MedWatch.• Use computerized databases to retrieve, document, and disseminate drug information.• Synthesize concise, applicable, comprehensive, evidence-based conclusions to medical staff inquires.• Prepare and deliver educational materials to healthcare professionals or lay audience that promote appropriate use of medications. • Safety compliance investigator for medication and technology utilization. Show less

• 

  Tuba City Regional Health Care Corporation

  Jul 2016 - Sept 2017

  Clinical Pharmacist

  • Therapeutic drug monitoring of individuals’ therapy for safety and efficacy. Report drug related adverse effects to FDA's MedWatch program.• Assist in the implementation and training of electronic health record system and prescribing technology.• Formulate and present drug monographs for Pharmacy and Therapeutics Committee.• Assist in establishing electronic guideline-based standard order sets for efficient regimen ordering.• Serve on the Sexually Transmitted Infection sub-committee as the expert pharmacist.• Conduct daily analysis of drug utilization reviews, drug contraindication overrides, drug-drug interactions and drug-allergy interactions.• Run a pharmacist led warfarin/anticoagulation clinic with a 1100+ visits/year.• Attend multi-disciplinary rounds to provide pharmacy-related input for patients’ therapeutic plans. • Counsel patients on prescription directions, adverse effects and precautions. Show less

• 

  UC San Diego School of Medicine

  Sept 2017 - May 2019

  Clinical Trials Regulatory Associate

  • Created a Pharmacy Manual and product labeling for a novel investigative product to be used during an Investigator Initiated Trial • Prepare clinical trial documents including: protocols, research plans, Investigational Drug (IND) factsheets, informed consent forms, and other regulatory related documents.• Manage regulatory issues during sponsors’ site initiation visits, monitoring visits, and investigator meetings.• Acting liaison for principal investigators and Clinical Trial sponsors/CRO’s.• Oversee document submissions and approvals from the Protocol Review and Monitoring Committee (PRMC) and Institutional Review Board (IRB). Show less

• 

  Community Hospital of the Monterey Peninsula

  Jun 2019 - Oct 2022

  Clinical Pharmacist

  • Emergency Department Pharmacy responsibilities including respond to Code Blue, RSI, and Stroke alerts hospital wide. • Established a hospital wide order set for C.diff treatment, as part of SIDP certification project.• Perform second verification of chemotherapy and other outpatient infusion orders.• Initiate and manage pharmacy protocols related to heparin, argatroban, warfarin, IV insulin, TPN, aminoglycosides, vancomycin, and inpatient pain management.• Monitor renally dosed medication use hospital wide and adjusted where appropriate and/or per protocol.• Night shift coverage as needed. Show less

• 

  UC San Diego Altman Clinical and Translational Research Institute

  Oct 2022 - now

  Research Pharmacist